Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Secured cards can be reported to bureaus quickly, affecting your score as activity is recorded. Learn timing and how to monitor updates.
9,942 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Analysts warn that electrifying AI data centers by 2030 could require $1.4 trillion in investment, driven by surging ...
U.S. stocks waver as tensions with Iran intensify, lifting wall street’s ‘fear gauge’ and driving a volatile session....
Goldman Sachs upgrades Liberty Energy and Patterson-UTI after surprising Q4 results, highlighting a growing gap betwe...
Target unveils a strategic shift toward daily essentials, anchoring growth on baby items and groceries while earmarki...
A recent filing shows Meros Investment Management sold a sizable block of Photronics shares. Learn what this kind of ...
A new stake in Vista Energy signals rising institutional interest in the energy sector. This article breaks down why ...
A draft U.S. framework for AI chip exports proposes tiered licensing, potentially slowing big orders and shifting mar...
Oracle defies the mood of a bruised AI rally, with Jefferies sticking to a buy and highlighting accelerating cloud gr...
A shift of production back to the United States is yielding more than branding for a leading self-defense maker. The ...
MP Materials is turning a quiet corner in the US defense supply chain, with Pentagon-backed pricing and a plan to bui...
Ford faced a massive quarterly loss tied to EV charges, while Winnebago posted a surprise profit swing on premium mot...